Intense research is ongoing in the development of small molecule inhibitors to specifically target membrane-bound CA(s) over cytosolic CAs to appraise the potential of targeting CAIX and CAXII to decrease tumor progression (Morris et al., 2011). The gene discussed is CA9; the disease is neoplasm.